Timothy Lu seeks to combat disease by reprogramming biological systems
Synthetic biologist hopes to develop treatments for cancer and other diseases.
Synthetic biologist hopes to develop treatments for cancer and other diseases.
New finding suggests differences in how humans and bacteria control production of DNA’s building blocks.
With SHERLOCK, a strip of paper can now indicate presence of pathogens, tumor DNA, or any genetic signature of interest.
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Department of Biology kicks off IAP seminar series with a lecture by synthetic-biology visionary George Church.
Study explains why mutations that would seemingly affect all cells lead to face-specific birth defects.
Improved methods validate the use of blood samples for studying patients’ cancer genomes.
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
Advance may open new pathways for cancer immunotherapy.
Biological engineers identify genes that protect against protein linked to Parkinson’s disease.
Awarded annually by The Rockefeller University, the award recognizes accomplishments of outstanding women in science.
Experiments confirm hypothesis about how the genome becomes organized into “neighborhoods.”
MIT associate professor and member of the Broad Institute and McGovern Institute recognized for commitment to invention, collaboration, and mentorship.
Five recipients honored for their fundamental and complementary accomplishments related to CRISPR-Cas9.
Biophysicist Ibrahim Cissé and cell biologist Gene-Wei Li honored as Pew Scholars; postdocs Ana Fiszbein and María Inda are named Pew Latin American Fellows.